Ono Pharmaceutical Ltd

4528.T · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

4,526 JPY (≈ 28.06 USD)

Margin of Safety

+46.4 %

Rating

BEOBACHTEN

Ono Pharmaceutical develops, manufactures, and markets prescription pharmaceuticals with a focus on immunology and oncology, with a patent-protected product portfolio—led primarily by the PD-1 inhibitor Opdivo in co-marketing—dominating revenue.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.